🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Smartphone Based Digital Screening for Aortic Valve Stenosis

Recruitingn/aAges 18 Years - anyAllMedical University Innsbruck
NCT07284550 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Heart valve diseases are among the most serious cardiovascular conditions in older age. One of the most common forms is aortic valve stenosis, a narrowing of the valve opening between the left ventricle and the main artery. As the valve becomes tighter, the heart must work harder and harder to pump blood through the body. This process often develops slowly over many years and initially causes no clear symptoms. As a result, the condition is frequently detected only in advanced stages, when warning signs such as shortness of breath, chest pain, or dizziness appear. Without treatment, aortic valve stenosis can become life-threatening. If detected early, however, very effective treatment options are available today. Up to now, the disease has been reliably diagnosed mainly through echocardiography. Yet this method is complex, costly, and requires specialized medical staff. A simple, afford

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
The following inclusion and exclusion criteria will be used for training, validation and test sets: Inclusion criteria for group I (moderate to severe AS): * Moderate to severe AS defined as AVA ≤ 1.5cm² in echocardiographic assessment * No other significant VHD, valvular prosthesis, pacemaker or congenital heart defect * Documented echocardiography as part of routine clinical practice no older than 90 days * Patient age ≥ 18 years * Provided written informed consent Inclusion criteria for group II: * No significant VHD, valvular prosthesis, pacemaker or congenital heart defect * Documented echocardiography as part of routine clinical practice no older than 90 days * Patient age ≥ 18 years * Provided written informed consent Exclusion criteria (applicable for all groups): • Informed consent form not signed.
💊

What it tests

  • Smartphone-based signal acquisition
📍

Where

1 site
Department of Internal Medicine III
Innsbruck, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy